Biochemical characteristics of inhaled antibiotics related to tolerability [0.03%]
吸入性抗生素的生化特性与其耐受性的关系
Manuel Vélez-Díaz-Pallarés,María Ángeles Parro-Martín,Hilario Martínez-Barros et al.
Manuel Vélez-Díaz-Pallarés et al.
Introduction: Inhaled antibiotics are used in the treatment of various respiratory diseases, including cystic fibrosis (CF), non-CF bronchiectasis, and ventilator-associated pneumonia. While some of these drugs are market...
[Translated article] Therapeutic drug monitoring of dalbavancin: A systematic review of strategies and clinical applications in the treatment of complex infections [0.03%]
达巴万星的治疗药物监测：复杂感染治疗中的策略和临床应用系统评价
Laura Moñino-Dominguez,Alicia Aguado-Paredes,Jaime Cordero-Ramos
Laura Moñino-Dominguez
Introduction: dalbavancin is approved for treating acute bacterial skin and soft tissue infections, but its off-label use for treating complex chronic infections has become increasingly common. Currently, there is no esta...
[Translated article] Influence of SARS-CoV-2 infection on the use of ceftazidime-avibactam in the critical patient [0.03%]
[SARS-CoV-2感染对重症患者使用头孢他啶-阿维巴坦的影响]
Fátima Mayo Olveira,José Manuel Caro Teller,María Dolores Canales Siguero et al.
Fátima Mayo Olveira et al.
Objective: The objective of the study was to analyse possible changes in antibiotic policy with ceftazidime-avibactam during the SARS-CoV-2 pandemic in an Intensive Care Unit (ICU) to determine patient mortality 28 days a...
Knowledge, perception, and willingness to implement the CMO (Capability- Motivation-Opportunity) methodology among specialist physicians caring for patients with HIV in Spain [0.03%]
西班牙专科医师关于在HIV患者中实施CMO方法的知识、认知和意愿调查
Enrique Contreras Macías,Pilar Taberner Bonastre,Anaïs Corma Gómez et al.
Enrique Contreras Macías et al.
Introduction: The CMO (Capability-Motivation-Opportunity) methodology is an innovative pharmaceutical care model designed to improve the quality of care for people living with HIV/AIDS (PLWHA). This approach evaluates the...
Isabel Romero Crespo,Maria Luisa Gaspar Carreño,Maria Cristina Muñoz Contreras
Isabel Romero Crespo
Objective: Review the most relevant aspects to consider when selecting the optimal surface disinfectant for use in healthcare settings. Method: ...
[Translated article] New Alzheimer disease's treatments: Hope or disappointment [0.03%]
新阿尔茨海默病治疗：希望还是失望？
Daniel Sevilla-Sánchez,Alejandro J Garza-Martínez
Daniel Sevilla-Sánchez
Acute esophageal necrosis in a patient with lung cancer under treatment with osimertinib: Case report [0.03%]
奥希替尼治疗肺癌患者的急性食管坏死1例报告
Alicia Aguado-Paredes,Laura Moñino-Dominguez,Maria Del Carmen Damas-Fuentes
Alicia Aguado-Paredes
Persistence of optimal and suboptimal response in chronic immune-mediated inflammatory diseases [0.03%]
慢性免疫介导性炎症性疾病中反应持续的最佳和非最佳状态
Joaquín Borrás-Blasco,Vicente Merino-Bohorquez,Esther Ramírez-Herráiz et al.
Joaquín Borrás-Blasco et al.
Standarization and characterization of intravenous drug dilutions in critically ill pediatric patients [0.03%]
危重儿童患者静脉用药配置的标准化和特征分析
Laura Torralba-Fernández,Marta García-Palomo,Miguel López de Abechuco-Ruiz et al.
Laura Torralba-Fernández et al.
Objective: To standardize the drug dilutions administered intravenously in a Pediatric Intensive Care Unit and to characterize these dilutions based on their pH, osmolarity, and vesicant nature. This aims to guide the sel...
Hilario Martínez-Barros,María Muñoz-García,Darío Antolín-Amérigo et al.
Hilario Martínez-Barros et al.
Objetives: To design the patient onboarding in a multidisciplinary severe asthma unit, according to the needs identified by patients and professionals in the unit. ...